We had a blast last night with Mohamad Alkhouli ‘s lab at #TCT2023. Extremely happy to reconnect with all the fellows and get to know the old and incoming ones. Thank you @aga_sularz for organizing a great gathering! We enjoyed every minute and every bite 😋

Mayra Guerrero, MD going over #MAC in the modern era! Have you heard of #MAC_Queen?👇🏽 Mayo Clinic CV #CardioTwitter #ACCFIT

Last night, the Mayo Clinic Cardiovascular Services Mayo Clinic Rochester Cardiology Fellows 🫀 (and many of their mini-fellows/ghouls/goblins) celebrated Halloween together 🎃👻🦴! See how it went, at your own risk (beware of Takotsubo!)...

Congratulations to this year's ACC-MN FIT Jeopardy winners Conor Lane, Mahmoud Ismayl, M.D. and Dr. Samuel Huxley from Mayo Clinic Rochester Cardiology Fellows! #MCVF23

Had a great time representing Mayo Clinic Rochester Cardiology Fellows in the FIT jeopardy at #MCVF23, thanks to Rekha Mankad, MD and ACC Minnesota Chapter for hosting. On to nationals!

In patients w/ cardiovascular disease & overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8 mos. Full SELECT trial results: nej.md/465pj91 #AHA23 AHA Science

Can deep learning be utilized to estimate LVEF from routine coronary angiographic images? Read our latest publication sciencedirect.com/science/articl…

Great insights from the great Kim Eagle at the Mayo Clinic Rochester Cardiology Fellows Fellowship Education Day #cvPrev

This #JACCINT study delves into the incidence, predictors, and clinical impact of persistent and recurrent #DRT post #LAAO 📊⚠️ bit.ly/47ThkNs Benjamin Hibbert Hussam Suradi Ashish Pershad Carlos E. Sanchez MD Rachel Kaplan

Read 10 key points to remember from a state-of-the-art review on the clinical impact, predictors, classification, and management of device-related thrombus after LAAO: bit.ly/3GuZQv6

The Mayo Clinic Rochester Cardiology Fellows family hanging out at American College of Cardiology #ACC24! A 💪🏻 first conference day, with countless presentations, posters, interviews, smiles, hugs, and general mischief 💓! Say hi if you see us! Mayo Clinic CV Mayo Clinic FITsOnTheGo

Presented today at #ACC24: In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t

mandeep singh presents our findings from the CHAMP Trial. #Genotype-guided P2Y12 inhibitor monotherapy within a week of #PCI is feasible and likely safe in patients with #HBR. Rajiv Gulati Chet Rihal Amir Lerman Naveen Pereira Linnea Baudhuin, PhD 🧬 Ann Moyer #ACC2024 🫀🩸

Check out this #JACCINT state-of-the-art review discussing the contemporary assessment and management of tricuspid regurgitation bit.ly/3Jf2VRw #vhdTR #CathLab Garrett Welle, MD Mack Eleid RTHahnMD

What a privilege to learn from some of the best in the business at #Fellows2024! Thanks again to Cardiovascular Research Foundation and all the faculty for this fantastic opportunity.

🔍 Exciting findings from the AEGIS-II Trial are in! 🎉 Discover how this breakthrough therapy could redefine cardiovascular care with C. Michael Gibson MD💪 @accintouch @mayoclinic Conor Lane Baim Institute #ACC2024 #ACCFIT #CardioTwitter youtu.be/cCWSu2bLzSE?si…

We evaluated 820 patients treated with TS MViR using the Sapien 3/Ultra/RESILIA THVs between Aug 2015 and Dec 2022 who were enrolled in the STS/ACC TVT Registry. We found a significant reduction in MR and sustained improvement in symptoms at 1 year. Mean mitral gradients were

🎈Expanding LM bifurcation aneurysm 🎈Use of neuro web device 🎈#RadialFirst 🎈Hugely fortunate to work with and learn from talented colleagues @WBrinjikji Conor Lane Mayo Clinic CV

Genotype-Guided P2Y12i Monotherapy Within 7 Days of PCI in High Bleeding Risk Patients: The CHAMP Trial - Pilot Study & Safety Assessment 📝Genotype-guided P2Y12 inhibitor monotherapy within a week of PCI is feasible and likely safe in patients with HBR. sciencedirect.com/science/articl…

The Mayo Clinic CV & Mayo Clinic Cardiac Surgery partners w/leading institutions in Mexico to perform North America’s first Silara MiBridgeTransseptal Direct Mitral Annuloplasty! Our groundbreaking Mayo team included Drs. Mayra Guerrero, Kimberly Holst, Sari Padang & Sorin Pislaru.